Translational and Precision Medicine focuses on converting scientific knowledge from the lab directly into improved health outcomes through personalized treatment strategies.
Genomics allows for a deeper understanding of the genetic basis of cancer, leading to tailored therapies that target specific mutations within tumors.
Biomarkers are biological indicators that can help identify disease presence and progression, enabling early diagnosis and targeted therapies.
Computational tools analyze large data sets, improve the accuracy of diagnoses, and contribute to innovative treatment solutions through machine learning.
I am open to collaborations in genomics, precision medicine, and computational biology, focusing on translational health research.
Stay connected by following my profiles on Google Scholar, ResearchGate, and other academic platforms.